
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the worlds leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. For more information, please visit: www.samsungbioepis.com. To see our community guidelines, please visit: bit.ly/2l0yiI3
Biosimilars,pharmaceutical,biopharmaceutical,biotechnology,regulatory affairs,clinical trials,research and development,novel biologic,oncology,immunology,ophthalmology,science,quality,innovation,and healthcare
Samsung bioepis operates in the Pharmaceutical manufacturing industry.
Samsung bioepis's revenue is 101m - 500m
Samsung bioepis has 1001 - 5000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.